# Novellus, Inc. — Form D

Novellus, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-16. The offering totals $2.5M, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-07-16
- Form: D
- Accession: 0001613814-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $250K
- Remaining: $2.3M
- Investors: 1
- Date of first sale: 2014-05-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-221163

## Issuer

- Name: Novellus, Inc.
- CIK: 0001613814
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 8 MUSEUM WAY #2204, CAMBRIDGE, MA, 02141
- Phone: (781) 640 1031

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Angel | Director | Brisbane, CA |
| Christopher Rohde | Director | Plano, TX |
| Matthew Angel | Executive Officer | Brisbane, CA |
| Christopher Rohde | Executive Officer | Plano, TX |

## More

- [CIK 1613814 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1613814&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001613814-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.